Literature DB >> 16608852

Membrane accumulation of influenza A virus hemagglutinin triggers nuclear export of the viral genome via protein kinase Calpha-mediated activation of ERK signaling.

Henju Marjuki1, Mohammad I Alam, Christina Ehrhardt, Ralf Wagner, Oliver Planz, Hans-D Klenk, Stephan Ludwig, Stephan Pleschka.   

Abstract

Replication and transcription of the influenza virus genome takes place exclusively within the nucleus of the infected cells. The viral RNA genome, polymerase subunits, and nucleoprotein form ribonucleoprotein (RNP) complexes. Late in the infectious cycle RNPs have to be exported from the nucleus to be enwrapped into budding progeny virions at the cell membrane. This process requires viral activation of the cellular Raf/MEK/ERK (mitogen-activated protein kinase (MAPK)) signaling cascade that is activated late in the infection cycle. Accordingly, block of the cascade results in retardation of RNP export and reduced titers of progeny virus. In the present study we have analyzed the importance of cell-membrane association of the viral hemagglutinin glycoprotein for viral MAPK activation. We show that hemagglutinin membrane accumulation and its tight association with lipid-raft domains trigger activation of the MAPK cascade via protein kinase Calpha activation and induces RNP export. This may represent an auto-regulative mechanism that coordinates timing of RNP export to a point when all viral components are ready for virus budding.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16608852     DOI: 10.1074/jbc.M510233200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  53 in total

1.  Identification and characterization of three novel nuclear export signals in the influenza A virus nucleoprotein.

Authors:  Maorong Yu; Xiaoling Liu; Shuai Cao; Zhendong Zhao; Ke Zhang; Qing Xie; Caiwei Chen; Shengyan Gao; Yuhai Bi; Lei Sun; Xin Ye; George F Gao; Wenjun Liu
Journal:  J Virol       Date:  2012-02-15       Impact factor: 5.103

2.  NS reassortment of an H7-type highly pathogenic avian influenza virus affects its propagation by altering the regulation of viral RNA production and antiviral host response.

Authors:  Zhongfang Wang; Nicole C Robb; Eva Lenz; Thorsten Wolff; Ervin Fodor; Stephan Pleschka
Journal:  J Virol       Date:  2010-08-25       Impact factor: 5.103

3.  Actin mediates the nanoscale membrane organization of the clustered membrane protein influenza hemagglutinin.

Authors:  Manasa V Gudheti; Nikki M Curthoys; Travis J Gould; Dahan Kim; Mudalige S Gunewardene; Kristin A Gabor; Julie A Gosse; Carol H Kim; Joshua Zimmerberg; Samuel T Hess
Journal:  Biophys J       Date:  2013-05-21       Impact factor: 4.033

4.  Inhibition of MLC phosphorylation restricts replication of influenza virus--a mechanism of action for anti-influenza agents.

Authors:  Mehran Haidari; Wei Zhang; Leila Ganjehei; Muzammil Ali; Zhenping Chen
Journal:  PLoS One       Date:  2011-06-23       Impact factor: 3.240

5.  Atorvastatin restricts the ability of influenza virus to generate lipid droplets and severely suppresses the replication of the virus.

Authors:  Donna Episcopio; Sarah Aminov; Shawna Benjamin; Gabrielle Germain; Emmanuel Datan; Joselyn Landazuri; Richard A Lockshin; Zahra Zakeri
Journal:  FASEB J       Date:  2019-05-24       Impact factor: 5.191

6.  Host regulatory network response to infection with highly pathogenic H5N1 avian influenza virus.

Authors:  Chengjun Li; Armand Bankhead; Amie J Eisfeld; Yasuko Hatta; Sophia Jeng; Jean H Chang; Lauri D Aicher; Sean Proll; Amy L Ellis; G Lynn Law; Katrina M Waters; Gabriele Neumann; Michael G Katze; Shannon McWeeney; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2011-08-24       Impact factor: 5.103

7.  The epidermal growth factor receptor (EGFR) promotes uptake of influenza A viruses (IAV) into host cells.

Authors:  Thorsten Eierhoff; Eike R Hrincius; Ursula Rescher; Stephan Ludwig; Christina Ehrhardt
Journal:  PLoS Pathog       Date:  2010-09-09       Impact factor: 6.823

8.  Innate immunity to influenza virus: implications for future therapy.

Authors:  Mitchell R White; Mona Doss; Patrick Boland; Tesfaldet Tecle; Kevan L Hartshorn
Journal:  Expert Rev Clin Immunol       Date:  2008-07-01       Impact factor: 4.473

9.  Differential regulation of type I interferon and epidermal growth factor pathways by a human Respirovirus virulence factor.

Authors:  Grégory Caignard; Anastassia V Komarova; Mehdi Bouraï; Thomas Mourez; Yves Jacob; Louis M Jones; Flore Rozenberg; Astrid Vabret; François Freymuth; Frédéric Tangy; Pierre-Olivier Vidalain
Journal:  PLoS Pathog       Date:  2009-09-18       Impact factor: 6.823

Review 10.  Influenza virus morphogenesis and budding.

Authors:  Debi P Nayak; Rilwan A Balogun; Hiroshi Yamada; Z Hong Zhou; Subrata Barman
Journal:  Virus Res       Date:  2009-05-27       Impact factor: 3.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.